Publication:
Effect of grinding of β-cyclodextrin and glibenclamide on tablet properties. Part I. In vitro

dc.contributor.authorAmpol Mitrevejen_US
dc.contributor.authorNuttanan Sinchaipaniden_US
dc.contributor.authorVaraporn Junyapraserten_US
dc.contributor.authorLadda Warintornuwaten_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T07:23:29Z
dc.date.available2018-07-04T07:23:29Z
dc.date.issued1996-01-01en_US
dc.description.abstractPhysical properties including dissolution characteristics of glibenclamide (GB) tablets were studied. Directly compressed and wet-granulated GB tablets gave only 35% and 40% drug dissolved, respectively. Physical mixing, kneading, and grinding of β-cyclodextrin (CD) with CB were investigated. It was found that the grinding method could markedly enhance the release of drug from the tablets. The physical properties of these tablets were unchanged after they had been stored at 40°C and 75% RH for at least 3 months. The GB/CD mixture at a ratio of 1 to 4, ground for 24 or 48 hr, exhibited superior dissolution and chemical stability. Differential scanning calorimetry indicated that an inclusion complex was produced. Decreasing grinding time or CD concentration could result in incomplete formation of the inclusion complex. It was concluded that pretreatment of the drug with CD by the grinding method could significantly improve the dissolution and stability of GB tablets.en_US
dc.identifier.citationDrug Development and Industrial Pharmacy. Vol.22, No.12 (1996), 1237-1241en_US
dc.identifier.doi10.3109/03639049609063243en_US
dc.identifier.issn03639045en_US
dc.identifier.other2-s2.0-0029802558en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/17582
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0029802558&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleEffect of grinding of β-cyclodextrin and glibenclamide on tablet properties. Part I. In vitroen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0029802558&origin=inwarden_US

Files

Collections